Christopher King, MD

Associate Medical Director, Advanced Lung Disease and Transplant Program

PFF Center Director

System Director, Respiratory Therapy

Financial relationships

Attribution:
Self

Type of financial relationship:
Consulting Fee

Ineligible company:
United Therapeutics

Date added:
04/06/2023

Date updated:
02/02/2024
Attribution:
Self

Type of financial relationship:
Consulting Fee

Ineligible company:
Merck

Date added:
04/06/2023

Date updated:
02/02/2024
Attribution:
Self

Type of financial relationship:
Consulting Fee

Ineligible company:
Altavant

Date added:
04/06/2023

Date updated:
02/02/2024

Return to 2023 ISHV Cath, Heart and Lung Conferences 12/27/2023